Streamlining Gastroenterology Prior Authorization with Klivira: Addressing Notable Health Workflow Challenges

Klivira transforms gastroenterology prior authorization, offering a specialized automation solution that navigates the complex workflows often addressed by platforms like Notable Health.

Revenue cycle leaders and prior authorization teams in gastroenterology practices face unique hurdles, from high-volume biologic renewals to intricate procedure approvals. While automation platforms like Notable Health aim to alleviate these burdens, a deep understanding of GI-specific nuances is critical for effective prior authorization management. Klivira provides targeted automation designed to integrate seamlessly and accelerate approvals for critical GI treatments and diagnostics.

The Unique Prior Authorization Landscape in Gastroenterology

Gastroenterology practices contend with a high volume of prior authorizations, particularly for chronic conditions like Inflammatory Bowel Disease (IBD) requiring biologics such as Humira, Stelara, Skyrizi, and Entyvio. Beyond specialty drugs, complex endoscopic procedures, advanced imaging (MRCP, CT enterography), and even specific functional GI disorder medications frequently trigger PA requirements. This complexity demands a robust automation strategy.

High-Volume Prior Authorization Triggers in Gastroenterology

**IBD Biologics**: Chronic treatment for Crohn's and Ulcerative Colitis, demanding ongoing re-authorization and adherence to ACG/AGA guidelines for step therapy.
**Hepatitis C DAAs**: Medications like Epclusa and Mavyret, requiring precise genotype, fibrosis stage, and prior-treatment documentation.
**Advanced Imaging**: MR enterography and CT enterography for IBD assessment, with specific clinical justification requirements.
**Endoscopic Procedures**: Capsule endoscopy (CPT 91110), ERCP, and EUS, often requiring prior workup and specific indications.
**Specialty Functional GI Drugs**: Medications such as Viberzi, Motegri, Linzess, and Trulance, necessitating Rome criteria documentation and conservative therapy trials.

Navigating Payer Policies and Clinical Guidelines for GI PA

Effective gastroenterology prior authorization requires meticulous adherence to clinical guidelines from bodies like ACG, AGA, and AASLD, alongside diverse payer-specific medical necessity criteria. Automation platforms must incorporate this intelligence to manage step therapy requirements for biologics, biosimilar mandates, and the critical distinction between treatment-naive vs. treatment-experienced pathways for both IBD and Hepatitis C.

Mitigating Frequent Gastroenterology PA Denials

**Step Therapy Non-Compliance**: Klivira's logic enforces payer-specific step therapy for IBD biologics, preventing denials for agents like TNF inhibitors or non-TNF alternatives.
**Incomplete Screening Documentation**: Automated checks ensure pre-biologic TB and hepatitis screenings are documented, addressing common gaps.
**Missing Disease Severity Scores**: The platform prompts for required Mayo scores, CDAI, or Harvey-Bradshaw indices to justify biologic use.
**Fibrosis Stage Gaps for Hep C DAAs**: Klivira ensures all necessary genotype and fibrosis stage documentation is captured for Hep C DAA approvals.
**Biosimilar Substitution Issues**: Our system identifies and routes based on payer mandates for biosimilar-first policies, reducing unnecessary denials.

Klivira's Differentiated Approach to Gastroenterology Automation

While general automation platforms like Notable Health offer broad solutions, Klivira specializes in the intricate demands of prior authorization, particularly within gastroenterology. Our platform leverages SMART on FHIR and X12 278 standards for EMR integration, automating data extraction for IBD biologics, Hep C DAAs, and diagnostic procedures. We provide specific workflows for chronic-treatment re-authorization and intelligent routing based on medical-vs-pharmacy benefit splits, ensuring comprehensive coverage for GI practices.

Seamless Integration and Workflow Optimization

Klivira connects directly with your EMR, pulling relevant clinical data to pre-populate authorization requests. This integration minimizes manual data entry, speeds up submission, and reduces errors that lead to denials. Our system understands the cyclic nature of GI procedures and chronic biologic treatment, proactively managing re-authorization schedules and adapting to changes in payer policies or patient treatment status.

Frequently asked questions

How does Klivira handle the distinction between medical and pharmacy benefit for GI biologics?

Klivira's platform is designed to identify whether a biologic for IBD, such as Humira or Stelara, falls under the medical or pharmacy benefit based on its administration mode. This intelligent routing ensures the correct PA pathway is followed, adapting as a patient's treatment regimen or payer policy evolves.

Can Klivira help with prior authorizations for advanced GI imaging like MR enterography?

Yes, Klivira streamlines prior authorizations for advanced GI imaging. Our system prompts for the specific clinical justifications, prior imaging history, and conservative-evaluation workup completion often required by payers for procedures like MRCP or MR enterography, reducing manual effort and improving approval rates.

How does Klivira address step therapy requirements for IBD biologics?

Klivira incorporates ACG/AGA-guideline-aware step therapy logic directly into the prior authorization workflow for IBD biologics. The system guides users through required conventional therapy trials (e.g., 5-ASA, immunomodulators) or specific biologic sequencing mandates (e.g., TNF inhibitors before non-TNF agents), ensuring compliance with payer policies.

Does Klivira support re-authorization for chronic GI conditions?

Absolutely. For chronic conditions like IBD, where biologics require periodic re-authorization (typically every 6 or 12 months), Klivira automates the re-authorization workflow. It proactively tracks due dates, prompts for updated disease response documentation, and facilitates timely resubmission to ensure continuity of care.

How does Klivira integrate with our existing EMR for gastroenterology workflows?

Klivira integrates with your EMR using industry standards like SMART on FHIR, allowing for automated extraction of relevant clinical data. This includes patient demographics, medication history, lab results (e.g., genotype, fibrosis stage for Hep C), and procedure notes, significantly reducing manual data entry for prior authorization requests.